| HOME >> BIOLOGY >> TECHNOLOGY |
About Impetigo
Impetigo, a contagious skin infection that usually produces blisters or sores on the face, neck, hands, and diaper area, is one of the most common skin infections among children. It also occurs in adults. Impetigo is contagious and can be spread from one person to another through close contact or by sharing towels, sheets, clothing, toys, or other items. Scratching can also spread the sores to other parts of the body.
Impetigo is caused by one of two types of bacteria - strep (streptococcus) or staph (staphylococcus). Often these bacteria enter the body when the skin has already been irritated or injured due to other skin problems such as eczema, poison ivy, insect bites, chickenpox, burns, or cuts. Children may develop impetigo after having a cold or allergies that have caused the skin under the nose to become raw. However, impetigo can also develop in completely healthy skin.
About Galderma
Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a global leading pharmaceutical company dedicated exclusively to the field of dermatology. The company is present in 65 countries with over 1000 sales representatives and is committed to improving the health of skin with an extensive line of innovative medical, corrective and aesthetic solutions to treat a range of dermatological conditions including: acne, rosacea, fungal nail infections, psoriasis & other steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence. Galderma has research and development facilities located in Sophia Antipolis (France), Princeton, New Jersey (USA), and Tokyo (Japan). Leading worldwide dermatology brands include Differin(R), Epiduo(R), Oracea(R), MetroGel(R) 1%, Rozex(R), Clobex(R), Tri-Luma(R), Loceryl(R) and Cetaphil(R). For more information on Galderma, visit '/>"/>
| SOURCE NovaBay Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved |